Proteoglycan Replacement Therapy
Proteoglycans are essential regulators of metabolic pathways in all humans. It is documented in multiple clinical papers and published in leading peer reviewed journals that even a small increase in the metabolic balance of proteoglycans is likely to exert a disproportionally large impact on their effectiveness.
Proteoglycan Replacement Therapy Works Actively with the Hair Growth Cycle
As Proteoglycan Follicular Atrophy is the underlying aetiology for a disrupted Hair Growth Cycle and follicular miniaturisation, the pharmacologic enhancement of key proteoglycan content and synthesis in and around the follicle presents an attainable therapeutic target in treating both Female Pattern Hair Loss and Telogen Effluvium.
One available and safe method of increasing the concentration of specific hair follicle proteoglycans and normalising the Hair Growth Cycle is to orally administer bioavailable proteoglycans, referred to as Proteoglycan Replacement Therapy.
This targeted approach to addressing Proteoglycan Follicular Atrophy counteracts any negative imbalance to the Hair Growth Cycle induced by Follicular Hypo-Glycania and has proven to be effective in treating female and male hair loss globally.
Proteoglycan Replacement Therapy is widely used as a monotherapy or as part of any multitherapy approach.